Latest Share Issuance News

Brazilian Critical Minerals (ASX: BCM) has reinforced the scale and quality of its Ema rare earth project with strong drilling results and steady progress on permitting and feasibility studies, positioning it well amid tightening global supply.

Peninsula Energy has won a Supreme Court ruling validating a contentious nearly 20 million share issuance from February despite prospectus lapses, prompting a request to lift its trading suspension.

Taiton Resources has completed a partial placement of 9.55 million shares to sophisticated investors, extending related option expiry dates to June 2029. A further tranche awaits due to delayed funds, while the company continues to advance exploration projects across South Australia and New South Wales.

Peninsula Energy (ASX: PEN) has voluntarily suspended trading of its shares pending a Supreme Court decision on the validity of share sales made earlier this year. The court hearing, set for 22 April, will determine if required disclosures were properly made for sales between February and April 2026.

Accordant Group Limited’s shareholders have approved a significant share issuance under a Rights Offer, allowing the Hull Family Trust to increase its voting control beyond 20%. The move also greenlights additional share allocations to related parties to cover subscription shortfalls.

Henderson Far East Income Limited posted a robust 23.3% net asset value total return for the half-year ending February 2026, supported by strong Asian tech and financial sector gains. The trust declared a 6.25p interim dividend and raised £39.1 million through new share issuance, securing a spot in the FTSE 250.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Vectus Biosystems has completed the sale of its VB4-P5 renal fibrosis compound to Canadian biotech XORTX, receiving a near 10% equity stake and warrants. This move aligns with Vectus’ strategy to develop drug candidates to a stage attractive to partners while focusing on its lead compound VB0004.

NT Minerals targets ASX reinstatement by acquiring the Endeavour Project via Slipstream Paynes Find, backed by a $810,000 entitlement offer and a planned share consolidation.

Solstice Minerals has successfully closed a $32.6 million placement and raised an additional $0.81 million through option exercises, issuing nearly 35 million new shares now available for immediate trading.

Dalaroo Metals has launched trading on the US OTCQB market, broadening its investor reach without diluting shares, while progressing its Greenland rare earth project with promising exploration results.

Magellan Financial Group Ltd (ASX:MFG) has moved closer to fully acquiring Barrenjoey Capital Partners, proposing to increase its ownership to 100% through a share issuance. The transaction, valued at approximately A$1.6 billion, has received positive market response and awaits shareholder and regulatory approvals.